Wellness Signal Monitor: Was Measles A Factor In This Pa. Woman’s Death?

A Pennsylvania woman who was unvaccinated likely died from measles complications, according to the county coroner. Details are still emerging.

How Govtech Innovates With Benefit Check Bots For Social Programs

Governments and nonprofits test AI-driven benefit check bots to streamline eligibility screening for social programs, addressing a $100B unclaimed benefit gap.

How Community Cohorts Can Reduce Screen Time Excess

Structured group recovery programs for phone addiction are being tested as an effective method for adults who have failed traditional blockers, with pilot plans underway.

Father-to-daughter Bone Marrow Transplant Gives Daughter A Second Chance At Life

A father successfully donated bone marrow to his daughter, offering her a second chance at life. The procedure highlights advances in family-based transplants.

In HelloNation, Endodontic Expert Dr. Allen Meier Of Bloomington, IN, Discusses The Lifespan Of A Root Canal

Dr. Allen Meier of Bloomington, IN, shares insights on the lifespan of root canal treatments amid rising public interest in endodontic procedures.

Biomerica Reports Fiscal 2026 Year-End Financial Results

Biomerica reports its fiscal 2026 year-end financial results, highlighting revenue, profit, and future outlook amid rising market interest.

Arch Biopartners Receives Central IRB Approval To Support U.S. Sites In Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial Of LSALT Peptide

Arch Biopartners receives Central IRB approval to support U.S. sites in Phase II trial of LSALT peptide for cardiac surgery-related kidney injury.

WuXi AppTec Continues To Reward Shareholders, Further Increasing Interim Dividend To RMB 1.51 Billion

WuXi AppTec has announced a further increase in its interim dividend to RMB 1.51 billion, continuing its shareholder reward strategy amid strong financial performance.

HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China

HUTCHMED announces trial results showing notable progression-free survival benefits with ORPATHYS® plus TAGRISSO® in lung cancer patients in China.

iBio, Inc. Files 8-K

iBio, Inc. has filed an 8-K with the SEC, disclosing recent corporate updates. Details are now available for investors and stakeholders.